These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 8968537
1. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226. Gicquiaux H, Tschöpl M, Doods HN, Bucher B. Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537 [Abstract] [Full Text] [Related]
4. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226. Lundberg JM, Modin A. Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732 [Abstract] [Full Text] [Related]
5. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. Doods HN, Wienen W, Entzeroth M, Rudolf K, Eberlein W, Engel W, Wieland HA. J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541 [Abstract] [Full Text] [Related]
7. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226. Wieland HA, Willim KD, Entzeroth M, Wienen W, Rudolf K, Eberlein W, Engel W, Doods HN. J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543 [Abstract] [Full Text] [Related]
8. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor. Holliday ND, Cox HM. Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416 [Abstract] [Full Text] [Related]
9. Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat? Zhao XH, Sun XY, Edvinsson L, Hedner T. J Hypertens; 1997 Jan; 15(1):19-27. PubMed ID: 9050966 [Abstract] [Full Text] [Related]
10. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435. Malmstrom RE, Lundberg JM. Eur J Pharmacol; 1995 Dec 29; 294(2-3):661-8. PubMed ID: 8750731 [Abstract] [Full Text] [Related]
13. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. Malmström RE. Acta Physiol Scand Suppl; 1997 Dec 29; 636():1-55. PubMed ID: 9179320 [Abstract] [Full Text] [Related]
14. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Sautel M, Rudolf K, Wittneben H, Herzog H, Martinez R, Munoz M, Eberlein W, Engel W, Walker P, Beck-Sickinger AG. Mol Pharmacol; 1996 Aug 29; 50(2):285-92. PubMed ID: 8700135 [Abstract] [Full Text] [Related]
15. Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors. Nilsson T, Erlinge D, Cantera L, Edvinsson L. J Cardiovasc Pharmacol; 1996 Dec 29; 28(6):764-8. PubMed ID: 8961073 [Abstract] [Full Text] [Related]
16. Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats. Zhao XH, Sun XY, Bergdahl A, Edvinsson L, Hedner T. J Pharm Pharmacol; 1999 Nov 29; 51(11):1257-65. PubMed ID: 10632083 [Abstract] [Full Text] [Related]
18. Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations. Tough IR, Cox HM. Eur J Pharmacol; 1996 Aug 22; 310(1):55-60. PubMed ID: 8880067 [Abstract] [Full Text] [Related]
19. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Bischoff A, Avramidis P, Erdbrügger W, Münter K, Michel MC. Br J Pharmacol; 1997 Apr 22; 120(7):1335-43. PubMed ID: 9105710 [Abstract] [Full Text] [Related]
20. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo. Malmström RE, Balmér KC, Lundberg JM. Br J Pharmacol; 1997 Jun 22; 121(3):595-603. PubMed ID: 9179405 [Abstract] [Full Text] [Related] Page: [Next] [New Search]